BlackRock · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
BlackRock Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 23.2M | $9.2B | — |
| 2024Q2 | 26.0M | $10.2B | +10.2% |
| 2024Q3 | 26.8M | $10.3B | +1.7% |
| 2024Q4 | 28.1M | $9.1B | -11.6% |
| 2025Q1 | 27.1M | $10.7B | +17.8% |
| 2025Q2 | 46.9M | $10.0B | -7.3% |
| 2025Q3 | 31.0M | $8.9B | -11.2% |
| 2025Q4 | 33.7M | $10.9B | +23.0% |
| 2026Q1 | 34.9M | $10.8B | -1.0% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F